Daily BriefsIndia

Daily Brief India: Max Healthcare Institute, Kovai Medical Center And Hos, HDFC Bank, Vedanta Resources, Vikram Solar, Jindal Steel, Jindal Stainless and more

By August 26, 2025 September 8th, 2025 No Comments

In today’s briefing:

  • Quiddity NIFTY Sep25 Results: 13/14 Predictions Correct; Only One Surprise; ~US$1.2bn One-Way
  • Business Breakdown: Kovai Medical – A Regional Leader in a Growing National Market
  • HDFC Bank Limited:  Record Ownership and Dominance Among EM Financials
  • Lucror Analytics – Morning Views Asia
  • Vikram Solar IPO Trading – Robust Insti-Led Demand; Decent Anchor
  • Jindal Steel Ltd (JINDALSTEL IN): Margin Resilience Amid Volume Softness; Capex-Fueled Growth Intact
  • Jindal Stainless (JSL): Monopoly Strength Supports Growth—Accumulate on Weakness


Quiddity NIFTY Sep25 Results: 13/14 Predictions Correct; Only One Surprise; ~US$1.2bn One-Way

By Janaghan Jeyakumar, CFA

  • The semiannual index rebal events of the NIFTY 50 index and NIFTY 100 index will take place in September 2025. The index changes were announced on Friday 22nd August 2025.
  • There will be two changes for NIFTY 50 index and five changes to NIFTY 100.
  • In this insight, we take a look at our final flow expectations.

Business Breakdown: Kovai Medical – A Regional Leader in a Growing National Market

By Sudarshan Bhandari

  • Kovai Medical is entering Chennai with a 300–400 bed facility, marking its first move beyond Coimbatore and strengthening its presence in a high-growth metro market.
  • The medical college now contributes 7% of revenue, up from 3% in FY22, ensuring recurring cash flows and deeper clinical-academic integration.
  • Consistent investments in advanced robotics and AI-driven systems enhance KMCH’s differentiation, positioning it to capture premium demand and medical tourism opportunities in Southern India.

HDFC Bank Limited:  Record Ownership and Dominance Among EM Financials

By Steven Holden

  • ChatGPT said: HDFC Bank is now held by 71% of active EM funds — an all-time high, with steady inflows and just one exit in six months.
  • Aggressive Growth funds show strongest conviction, with multiple holders above a 7% weight.
  • Post-Merger, HDFC has widened its lead over ICICI and regional peers, cementing its role as EM managers’ core financials exposure.

Lucror Analytics – Morning Views Asia

By Trung Nguyen

  • In today’s Morning Views publication we comment on developments of the following high yield issuers: Vedanta Resources, JSW Infrastructure
  • UST yields plummeted on Friday, led by the short end, as the market priced in greater rate-cut expectations after Fed Chairman Jerome Powell signalled openness (albeit he remained non-committal) towards interest-rate reductions.
  • The UST curve bull steepened, with the yield on the 2Y UST falling 10 bps to 3.70%, while that on the 10Y UST declined 7 bps to 4.25%.

Vikram Solar IPO Trading – Robust Insti-Led Demand; Decent Anchor

By Akshat Shah

  • Vikram Solar (0490158D IN) raised about US$238m in its India IPO.
  • Vikram Solar is an integrated solar photo-voltaic modules producer and an integrated solar energy solutions provider offering engineering, procurement and construction services, and operations and maintenance services to its customers.
  • We have looked at the company’s past performance and valuations in our previous notes. In this note, we will talk about the trading dynamics.

Jindal Steel Ltd (JINDALSTEL IN): Margin Resilience Amid Volume Softness; Capex-Fueled Growth Intact

By Rahul Jain

  • Q1 FY26 saw stable production but weaker volumes, with EBITDA/t surging 35% QoQ to ₹15,680 on coal savings and higher VAS mix.
  • Capacity ramp-up to 15.9 MT by FY27, coupled with >70% VAS share, drives a strong ~40% PAT CAGR through FY29.
  • Trades at 16.2× P/E and 9.2× EV/EBITDA (FY26E), offering upside potential versus JSW’s premium multiples.

Jindal Stainless (JSL): Monopoly Strength Supports Growth—Accumulate on Weakness

By Rahul Jain

  • Jindal Stainless delivered solid Q1 FY26 performance with margin recovery, healthy domestic demand, and subsidiaries turning incrementally accretive.
  • Management is guiding 9–10% volume CAGR with stable EBITDA/ton, supported by downstream capex, Chromeni ramp-up, and the Maharashtra greenfield project (Phase 1 by FY29–30).
  • The stock trades at a premium (~11–12× EV/EBITDA, ~18–22× P/E forward) versus peers, implying confidence in earnings compounding but limited scope for re-rating.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars